GB1394542A - Optically active isomers of hydroxyamines - Google Patents

Optically active isomers of hydroxyamines

Info

Publication number
GB1394542A
GB1394542A GB1284273A GB1284273A GB1394542A GB 1394542 A GB1394542 A GB 1394542A GB 1284273 A GB1284273 A GB 1284273A GB 1284273 A GB1284273 A GB 1284273A GB 1394542 A GB1394542 A GB 1394542A
Authority
GB
United Kingdom
Prior art keywords
general formula
dihalo
aminophenyl
compound
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1284273A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19722212600 external-priority patent/DE2212600C3/en
Priority claimed from DE19732300614 external-priority patent/DE2300614A1/en
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB1394542A publication Critical patent/GB1394542A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1394542 d- and l-1-(3,5-dihalo-4-aminophenyl)-2-aminoethanols DR KARL THOMAE GmbH 16 March 1973 [16 March 1972 8 Jan 1973] 12842/73 Heading C2C Novel d- and lisomers of 1-(3,5-dihalo-4- aminophenyl)-2-aminoethanols of the general formula wherein Hal is a chlorine or bromine atom, R 1 is a chlorine or bromine atom and R is a C 2-5 alkyl or C 3-6 cycloalkyl group, and physiologically compatible acid addition salts thereof are prepared by resolving a racemic mixture of the compound of the general formula above or a derivative or physiologically compatible acid addition salt thereof to separate the optically active isomers, recovering the desired (+)- and/or ( - )-isomer and, if necessary, converting the desired isomer of a derivative of a compound of the general formula above into the corresponding isomer of the said compound. Pharmaceutical compositions having a selective activity on adrenergic #-receptors comprise, as active ingredient, a d- or lisomer of a 1-(3,5- dihalo-4-aminophenyl)-2-aminoethanol of the above general formula or physiologically compatible acid addition salt thereof, in association with a pharmaceutical carrier or excipient.
GB1284273A 1972-03-16 1973-03-16 Optically active isomers of hydroxyamines Expired GB1394542A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19722212600 DE2212600C3 (en) 1972-03-16 d- and l-1- (4-Amino-3,5-dichlorophenyl) -2-alkylamino-ethanols and their acid addition salts, processes for their preparation and pharmaceuticals containing these compounds
DE19732300614 DE2300614A1 (en) 1973-01-08 1973-01-08 Optically active antipodes of substd aminophenylalkylamino - ethanols - from racemic mixts - selective activity on beta receptors

Publications (1)

Publication Number Publication Date
GB1394542A true GB1394542A (en) 1975-05-21

Family

ID=25762898

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1284273A Expired GB1394542A (en) 1972-03-16 1973-03-16 Optically active isomers of hydroxyamines

Country Status (17)

Country Link
JP (1) JPS491528A (en)
AT (1) AT322534B (en)
AU (1) AU471457B2 (en)
CH (1) CH584184A5 (en)
DD (1) DD107260A5 (en)
ES (1) ES412615A1 (en)
FI (1) FI56523C (en)
FR (1) FR2181828B1 (en)
GB (1) GB1394542A (en)
HU (1) HU165270B (en)
IL (1) IL41784A0 (en)
NL (1) NL176669C (en)
NO (1) NO136094C (en)
RO (1) RO62876A (en)
SE (1) SE396597B (en)
SU (1) SU446963A3 (en)
ZA (1) ZA731796B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
WO2001042193A1 (en) * 1999-12-08 2001-06-14 Theravance, Inc. β2-ADRENERGIC RECEPTOR AGONISTS
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6576793B1 (en) 1999-12-08 2003-06-10 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US8704002B2 (en) 2003-06-23 2014-04-22 Grünenthal GmbH Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)-amine compounds by heterogeneous catalysis
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
US8716349B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
US8791300B2 (en) 2005-11-02 2014-07-29 Gruenenthal Gmbh Process for preparing a substituted dimethyl-(3-arylbutyl)amine compound by homogeneous catalysis
US8877974B2 (en) 2006-07-24 2014-11-04 Grünenthal GmbH Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4063025A (en) 1975-02-05 1977-12-13 Yamanouchi Pharmaceutical Co., Ltd. 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives
GB1523974A (en) * 1975-02-05 1978-09-06 Yamanouchi Pharma Co Ltd 4-substituted amino- -aminomethylbenzyl alcohol derivatives
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
JPS6191160A (en) * 1984-10-09 1986-05-09 Nisshin Flour Milling Co Ltd Production of carnitine
US5169633A (en) * 1985-07-29 1992-12-08 American Cyanamid Company Continuous release phenylethanolamine derivative compositions
US5059422A (en) * 1985-07-29 1991-10-22 American Cyanamid Company Continuous release phenylethanolamine derivative compositions
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
EP1754474A1 (en) * 2005-02-02 2007-02-21 Eucro European Contract Research GmbH & Co. KG Use of S-Clenbuterol

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5552442A (en) * 1987-09-15 1996-09-03 The Rowett Research Institute Therapeutic applications of clenbuterol
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
US6916961B2 (en) 1999-06-02 2005-07-12 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US7211695B2 (en) 1999-06-07 2007-05-01 Theravance, Inc. β2-adrenergic receptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US7105701B2 (en) 1999-06-07 2006-09-12 Theravance, Inc. β2-adrenergic receptor agonists
WO2001042193A1 (en) * 1999-12-08 2001-06-14 Theravance, Inc. β2-ADRENERGIC RECEPTOR AGONISTS
US6576793B1 (en) 1999-12-08 2003-06-10 Theravance, Inc. β2-adrenergic receptor agonists
US8704002B2 (en) 2003-06-23 2014-04-22 Grünenthal GmbH Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)-amine compounds by heterogeneous catalysis
US8791300B2 (en) 2005-11-02 2014-07-29 Gruenenthal Gmbh Process for preparing a substituted dimethyl-(3-arylbutyl)amine compound by homogeneous catalysis
US8877974B2 (en) 2006-07-24 2014-11-04 Grünenthal GmbH Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol
US11739049B2 (en) 2006-07-24 2023-08-29 Grünenthal GmbH Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
US8716349B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders

Also Published As

Publication number Publication date
ZA731796B (en) 1974-11-27
AT322534B (en) 1975-05-26
RO62876A (en) 1977-10-15
SE396597B (en) 1977-09-26
IL41784A0 (en) 1973-05-31
NL176669B (en) 1984-12-17
FI56523B (en) 1979-10-31
DD107260A5 (en) 1974-07-20
AU471457B2 (en) 1976-04-29
NO136094B (en) 1977-04-12
NL176669C (en) 1985-05-17
NO136094C (en) 1977-07-20
AU5334573A (en) 1974-09-19
CH584184A5 (en) 1977-01-31
FR2181828A1 (en) 1973-12-07
ES412615A1 (en) 1976-01-01
HU165270B (en) 1974-07-27
FR2181828B1 (en) 1976-08-13
SU446963A3 (en) 1974-10-15
NL7303612A (en) 1973-09-18
JPS491528A (en) 1974-01-08
FI56523C (en) 1980-02-11

Similar Documents

Publication Publication Date Title
GB1394542A (en) Optically active isomers of hydroxyamines
GB1432576A (en) Substituted phenylacetic acids
GB1511463A (en) 1-acylamino methyl-1,2,3,4-tetrahydroisoquinolines
GB1216945A (en) Novel imidazoline derivatives, the preparation thereof and compositions containing the same
GB1228736A (en)
GB1265279A (en)
GB1496491A (en) Dihydroergopeptine derivatives
GB1455624A (en) Imidazoline derivatives
GB1500063A (en) Indolinone and fluorenone derivatives
GB1385150A (en) Sulphur-containing ring compounds and compositions thereof
GB1409898A (en) 1,1-dioxidothiazolidin-4-ones and processes for their manufacture
GB1497729A (en) Benzenesulphonyl ureas and process for their manufacture
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
GB1173809A (en) N-Substituted Nor-Morphines
GB1412932A (en) Pharmaceutically active leurosine derivatives and preparation thereof
GB1289227A (en)
SE7408868L (en)
GB1047267A (en)
GB1305725A (en)
GB1173562A (en) Chloramphenicol Ester Salts, the Preparation therof and Compositions Containing them
GB1353511A (en) Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
GB1318643A (en) Syndonimine derivatives the preparation thereof and compositions containing the same
GB1512930A (en) Substituted 4-hydroxybenzylidene malononitriles
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
GB1384523A (en) Oxime derivatives and their preparation

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee